Literature DB >> 11082824

Platelet monoamine oxidase B activity is inversely associated with plasma cotinine concentration.

I Berlin1, O Spreux-Varoquaux, J M Launay.   

Abstract

Cigarette smoke but not nicotine inhibits irreversibly platelet monoamine oxidase B (MAO-B) activity. Current smokers have decreased platelet MAO-B activity which normalizes when smokers quit. Normalization of platelet MAO-B activity probably depends on platelet turnover. Platelet MAO-B activity has been found to be correlated with plasma thiocyanate concentration. The aim of this study was to investigate in smokers whether platelet MAO-B activity is related to plasma cotinine concentration, an indirect index of use of smoked tobacco. We determined simultaneously plasma cotinine concentration and platelet MAO-B activity in 85 cigarette smokers [mean (+/- SD) age 39 +/- 8.8 years, 55 men]. Platelet MAO-B activity was lower in male than in female smokers (14.1 +/- 7.9 versus 17.8 +/- 7.2 nmol/h/10(9) platelets, p = 0.03). Platelet MAO-B activity correlated positively with age (r = 0.26, p = 0.01) and inversely with plasma cotinine concentration (r = -0.32, p = 0.002) but not with number of cigarettes smoked or with Fagerström Tolerance Questionnaire score. Multiple linear regression analysis showed that 49% of the age-adjusted variance in platelet MAO-B activity (R2 = 0.489, p < 0.0001) was explained by plasma cotinine concentration (p < 0.001) and gender (p = 0.037). It was concluded that platelet MAO-B activity in smokers is inversely associated with plasma cotinine level, an index of smoked tobacco use. Further studies are needed to investigate whether measurement of platelet MAO-B activity can be used as a long-term index of tobacco use and smoke exposure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082824     DOI: 10.1080/14622200050147501

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  3 in total

1.  Consistency of subjective responses to imagery-induced tobacco craving over multiple sessions.

Authors:  Dustin C Lee; Carol S Myers; Richard C Taylor; Eric T Moolchan; Ivan Berlin; Stephen J Heishman
Journal:  Addict Behav       Date:  2007-01-31       Impact factor: 3.913

Review 2.  Monoamine oxidase inhibition for tobacco pharmacotherapy.

Authors:  T P George; A H Weinberger
Journal:  Clin Pharmacol Ther       Date:  2007-12-19       Impact factor: 6.875

Review 3.  Monoamine oxidase inhibition in cigarette smokers: From preclinical studies to tobacco product regulation.

Authors:  Alan F Sved; Jillian J Weeks; Anthony A Grace; Tracy T Smith; Eric C Donny
Journal:  Front Neurosci       Date:  2022-08-16       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.